Virtu Financial’s China Pharma Holdings CPHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-934
Closed -$6K 1510
2023
Q4
$6K Sell
934
-1,402
-60% -$7.87K ﹤0.01% 1453
2023
Q3
$17K Buy
2,336
+1,910
+448% +$23.2K ﹤0.01% 1034
2023
Q2
$7K Buy
+426
New +$7.49K ﹤0.01% 1379
2022
Q3
Sell
-177
Closed -$19K 1799
2022
Q2
$19K Buy
177
+135
+321% +$18.1K ﹤0.01% 1339
2022
Q1
$8K Sell
42
-169
-80% -$35.3K ﹤0.01% 1377
2021
Q4
$51K Buy
211
+145
+220% +$39.6K 0.01% 1335
2021
Q3
$18K Sell
66
-51
-44% -$18.1K ﹤0.01% 1388
2021
Q2
$42K Buy
117
+28
+31% +$10.1K ﹤0.01% 1355
2021
Q1
$37K Sell
89
-58
-39% -$25K ﹤0.01% 1463
2020
Q4
$33K Buy
+147
New +$31.6K ﹤0.01% 1302
2019
Q4
$8K Sell
71
-15
-17% -$1.85K ﹤0.01% 1378
2019
Q3
$11K Buy
86
+28
+48% +$3.83K ﹤0.01% 1340
2019
Q2
$9K Buy
+58
New +$9.31K ﹤0.01% 1385
2019
Q1
Sell
-196
Closed -$25K 1464
2018
Q4
$25K Buy
+196
New +$28.5K ﹤0.01% 1354
2018
Q3
Sell
-29
Closed -$3K 1618
2018
Q2
$3K Sell
29
-1
-3% -$135 ﹤0.01% 1925
2018
Q1
$5K Sell
30
-34
-53% -$6.08K ﹤0.01% 1868
2017
Q4
$6K Sell
64
-89
-58% -$7.73K ﹤0.01% 2279
2017
Q3
$13K Buy
+153
New +$15.2K ﹤0.01% 2394

Other funds holding CPHI

Virtu Financial's CPHI Position: Q1 2024 in Review

Virtu Financial sold out of China Pharma Holdings (CPHI) in Q1 2024, closing a stake of 934 shares — an estimated $6K sold.

Virtu Financial first reported a position in CPHI in Q3 2017 and held it in 18 quarters. The position peaked at $51K in Q4 2021. 3 funds tracked by Wall St. Rank hold CPHI as of Q1 2024.

  • Virtu Financial reported no remaining China Pharma Holdings position as of Q1 2024 after selling out during the quarter.
  • Virtu Financial sold 934 China Pharma Holdings shares in Q1 2024, an estimated $6K.
  • Virtu Financial first reported a position in China Pharma Holdings in Q3 2017 and held it in 18 quarters.
  • Virtu Financial's China Pharma Holdings position peaked at $51K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held China Pharma Holdings as of Q1 2024.

Based on Virtu Financial's 13F filing for Q1 2024, filed 20 May 2024.